Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of N-acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis

NCT05122559 is registered in ClinicalTrials.gov with Emmanuelle Waubant, MD PhD as lead sponsor.

NCT NCT05122559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05122559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of N-acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis
Lead sponsor
Emmanuelle Waubant, MD PhD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 16, 2022
Completion date
February 28, 2027
Enrollment
98 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis, primary progressive, multiple sclerosis, secondary progressive